Similar articles

• TGF-β is associated with poor prognosis and promotes osteosarcoma progression via PI3K/Akt pathway activation.

  Ma K, Zhang C, Li W. Ma K, et al. Cell Cycle. 2020 Sep;19(18):2327-2339. doi: 10.1080/15384101.2020.1805552. Epub 2020 Aug 17. Cell Cycle. 2020. Retraction in: Cell Cycle. 2022 Apr;21(8):879. doi: 10.1080/15384101.2022.2046822. PMID: 32804027 Free PMC article. Retracted.
• Gamabufotalin suppressed osteosarcoma stem cells through the TGF-β/periostin/PI3K/AKT pathway.

  Ma K, Zhang C, Li W. Ma K, et al. Chem Biol Interact. 2020 Nov 1;331:109275. doi: 10.1016/j.cbi.2020.109275. Epub 2020 Sep 30. Chem Biol Interact. 2020. PMID: 33010222
• Knockdown of TBRG4 suppresses proliferation, invasion and promotes apoptosis of osteosarcoma cells by downregulating TGF-β1 expression and PI3K/AKT signaling pathway.

  Huang F, Zhou P, Wang Z, Zhang XL, Liao FX, Hu Y, Chang J. Huang F, et al. Arch Biochem Biophys. 2020 Jun 15;686:108351. doi: 10.1016/j.abb.2020.108351. Epub 2020 Mar 30. Arch Biochem Biophys. 2020. PMID: 32240636
• Transforming growth factor alpha promotes osteosarcoma metastasis by ICAM-1 and PI3K/Akt signaling pathway.

  Hou CH, Lin FL, Tong KB, Hou SM, Liu JF. Hou CH, et al. Biochem Pharmacol. 2014 Jun 15;89(4):453-63. doi: 10.1016/j.bcp.2014.03.010. Epub 2014 Mar 28. Biochem Pharmacol. 2014. PMID: 24685520
• PI3K/Akt signaling in osteosarcoma.

  Zhang J, Yu XH, Yan YG, Wang C, Wang WJ. Zhang J, et al. Clin Chim Acta. 2015 Apr 15;444:182-92. doi: 10.1016/j.cca.2014.12.041. Epub 2015 Feb 19. Clin Chim Acta. 2015. PMID: 25704303 Review.